Vitamin K to Attenuate Coronary Artery Calcification in Hemodialysis Patients
NCT01528800
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
85
Enrollment
OTHER
Sponsor class
Conditions
End-stage Kidney Disease
Interventions
DRUG:
Vitamin K1
DRUG:
Microcrystalline Methylcellulose
Sponsor
Dr. Rachel Holden